Why is Thyrocare Tech. falling/rising?

As of 10-Oct, Thyrocare Technologies Ltd is experiencing a price increase, currently at Rs 1,262.50, reflecting a rise of Rs 56.8 or 4.71%. The stock has shown strong performance today, outperforming its sector by 5.26% and reaching an intraday high of Rs 1,269.6. Over the past week, the stock has gained 7.06%, while its year-to-date return stands at an impressive 38.33%. Despite a recent decline in delivery volume, which fell by 34.26% against the 5-day average, the company maintains high management efficiency with a return on equity (ROE) of 20.45% and a low debt-to-equity ratio. Additionally, Thyrocare has reported significant growth in net profit and has consistently delivered positive results over the last six quarters, contributing to its favorable market perception.
In the broader market context, Thyrocare's short-term performance has significantly outpaced the Sensex, which has only increased by 1.59% over the same week. This strong relative performance highlights the stock's resilience and attractiveness to investors, particularly given its historical returns of 52.12% over the past year compared to the Sensex's modest 1.09%. However, concerns remain regarding its long-term growth potential, as net sales have only grown at an annual rate of 13.76% over the last five years, and the stock is trading at a premium compared to its peers. The fact that 100% of promoter shares are pledged could also pose risks in a declining market, potentially impacting investor confidence.